Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Roderick John Flower Insider Profile
4 Followers
Roderick John Flower, Director at Antibe Therapeutics, holds 185.14K shares in Antibe Therapeutics (Ticker: ATBPF).
Roderick John Flower has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Roderick John Flower's holdings
Insider Roles
Director
Roles that Roderick John Flower holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Oct 30, 2019 - Oct 30, 2020
Return:+36.40%
The most profitable trade made by Roderick John Flower
Roderick John Flower's Trading History
List of latest transactions for each holding click on a transaction to see Roderick John Flower's performance on stock
You May Also Like
Roderick John Flower insider profile FAQ
What is the percentage of profitable transactions made by Roderick John Flower?
The percentage of profitable transactions made by Roderick John Flower is ―.
What is the average return per transaction made by Roderick John Flower?
The average return per transaction made by Roderick John Flower is ―.
What stocks does Roderick John Flower hold?
Roderick John Flower holds: ATBPF stocks.
What was Roderick John Flower’s latest transaction?
Roderick John Flower latest transaction was an Uninformative Sell of ―.
What was Roderick John Flower's most profitable transaction?
Roderick John Flower’s most profitable transaction was an Informative Sell of ATBPF stock on October 30, 2019. The return on the trade was 36.40%.
What is Roderick John Flower's role in Antibe Therapeutics?
Roderick John Flower's role in Antibe Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.